These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 31889335)
1. Is the survival rate for acral melanoma actually worse than other cutaneous melanomas? Lim Y; Lee J; Lee DY J Dermatol; 2020 Mar; 47(3):251-256. PubMed ID: 31889335 [TBL] [Abstract][Full Text] [Related]
2. Prognosis of acral melanoma: a series of 281 patients. Bello DM; Chou JF; Panageas KS; Brady MS; Coit DG; Carvajal RD; Ariyan CE Ann Surg Oncol; 2013 Oct; 20(11):3618-25. PubMed ID: 23838913 [TBL] [Abstract][Full Text] [Related]
3. Slow Mohs Micrographic Surgery for Acral Melanoma Treatment in Korean Patients. Seo J; Oh Y; Kim SK; Roh MR; Chung KY Dermatol Surg; 2021 Feb; 47(2):e42-e46. PubMed ID: 33481431 [TBL] [Abstract][Full Text] [Related]
4. Treatment and outcomes of melanoma in acral location in Korean patients. Roh MR; Kim J; Chung KY Yonsei Med J; 2010 Jul; 51(4):562-8. PubMed ID: 20499423 [TBL] [Abstract][Full Text] [Related]
6. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis. Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787 [TBL] [Abstract][Full Text] [Related]
7. The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma. Wei X; Wu D; Li H; Zhang R; Chen Y; Yao H; Chi Z; Sheng X; Cui C; Bai X; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Mao L; Lian B; Kong Y; Dai J; Tang B; Yan X; Wang X; Li S; Zhou L; Balch CM; Si L; Guo J Ann Surg Oncol; 2020 Sep; 27(9):3478-3485. PubMed ID: 32253677 [TBL] [Abstract][Full Text] [Related]
8. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas. Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942 [TBL] [Abstract][Full Text] [Related]
9. Is sex an independent prognostic factor in cutaneous head and neck melanoma? Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966 [TBL] [Abstract][Full Text] [Related]
10. Predictors of mucosal melanoma survival in a population-based setting. Altieri L; Eguchi M; Peng DH; Cockburn M J Am Acad Dermatol; 2019 Jul; 81(1):136-142.e2. PubMed ID: 30296542 [TBL] [Abstract][Full Text] [Related]
11. The current management and prognosis of acral lentiginous melanoma. Wells KE; Reintgen DS; Cruse CW Ann Plast Surg; 1992 Jan; 28(1):100-3. PubMed ID: 1642394 [TBL] [Abstract][Full Text] [Related]
12. Tumor growth rate as a prognostic factor of acral melanoma in a Korean population. Jo G; Cho SI; Cho Y; Ohn J; Mun JH Medicine (Baltimore); 2020 May; 99(21):e19936. PubMed ID: 32481257 [TBL] [Abstract][Full Text] [Related]
13. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients. Kuchelmeister C; Schaumburg-Lever G; Garbe C Br J Dermatol; 2000 Aug; 143(2):275-80. PubMed ID: 10951133 [TBL] [Abstract][Full Text] [Related]
14. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma. Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703 [TBL] [Abstract][Full Text] [Related]
15. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Chang AE; Karnell LH; Menck HR Cancer; 1998 Oct; 83(8):1664-78. PubMed ID: 9781962 [TBL] [Abstract][Full Text] [Related]
16. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival. Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387 [TBL] [Abstract][Full Text] [Related]
17. Sentinel node location in trunk and extremity melanomas: uncommon or multiple lymph drainage does not affect survival. Gordon D; Smedby KE; Schultz I; Olsson H; Ingvar C; Hansson J; Gillgren P Ann Surg Oncol; 2014 Oct; 21(11):3386-94. PubMed ID: 24866434 [TBL] [Abstract][Full Text] [Related]
18. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma. Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600 [TBL] [Abstract][Full Text] [Related]
19. Survival of acral lentiginous melanoma in the National Cancer Institute of Colombia. Duarte CA; Flórez JP; López HG; Meneses MX; de Vries E J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):438-442. PubMed ID: 27518480 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneous spectrum of acral melanoma: A clinicoprognostic study of 213 acral melanomas according to tumor site. Moon HR; Kang HJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ J Am Acad Dermatol; 2018 Jan; 78(1):179-182.e3. PubMed ID: 29241776 [No Abstract] [Full Text] [Related] [Next] [New Search]